• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY PROMUS ELEMENT¿ PLUS; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY PROMUS ELEMENT¿ PLUS; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Model Number H7493911424250
Device Problem Occlusion Within Device (1423)
Patient Problems Reocclusion (1985); Chest Tightness/Pressure (2463)
Event Date 11/30/2016
Event Type  Injury  
Manufacturer Narrative
Device is a combination product.Device evaluated by mfr: it is indicated that the device will not be returned for evaluation.A review of the batch history, historical trending, and similar complaint trending review for the product family will be conducted.If there is any further relevant information from that review, a supplemental medwatch will be filed.(b)(4).
 
Event Description
(b)(6).It was reported that stent restenosis occurred.In (b)(6) 2013, the patient was diagnosed with unstable angina and was referred for cardiac catheterization.Subsequently, index procedure was performed.Target lesion #1 was a de novo lesion located in the proximal left anterior descending(lad) with 80% stenosis and was 8.00mm long with a reference vessel diameter of 2.50mm.Target lesion #1 was treated with pre-dilation and placement of 2.50x24.00mm promus element¿ plus drug-eluting stent(des).Following post-dilatation, residual stenosis was 0%.Target lesion #2 was a de novo lesion located in the mid lad with 95% stenosis and was 4.00mm long with a reference vessel diameter of 5.00mm.Target lesion #2 was treated with pre-dilation and placement of 3.50x20.00mm promus element plus des.Following post-dilatation, residual stenosis was 0%.Target lesion #3 was a de novo lesion located in the distal lad with 75% stenosis and was 3.00mm long with a reference vessel diameter of 10.00mm.Target lesion #3 was treated with pre-dilation and placement of 3.00x20.00mm promus element plus des.Following post-dilatation, residual stenosis was 0%.The following day, the patient was discharged on aspirin and clopidogrel.In october 2016, the patient presented to the hospital with the complaint of chest pressure and was referred for nuclear stress test which revealed the stress test was abnormal suggestive of apical to mid anteroseptal defect and transthoracic echocardiogram revealed ejection fraction to be 45%.Given these findings, the patient was referred for cardiac catheterization.In (b)(6) 2016, the subject was hospitalized in view of cardiac catheterization due to worsening coronary artery disease (cad).The 90% in-stent restenosis in the mid section of proximal lad, with timi flow 2, was treated with 3.5mmx18mm non-bsc des.Post treatment residual stenosis was 0%.In addition, the 90% stenosis located in proximal left circumflex(lcx) was treated with the placement of a 3.00x18mm non-bsc des and 3.00mmx9mm non-bsc des.During the procedure, positive distal obtuse marginal dissection was noted with good flow.Two days after, the event was resolved and the patient was discharged on the same day.
 
Manufacturer Narrative
Describe event or problem, relevant tests/lab data updated and corrected.(b)(4).
 
Event Description
It was further reported that target lesion #1 was located in the distal left anterior descending (lad).Target lesion # 2 was 5.00 mm long with reference vessel diameter of 4.0 mm.Target lesion #3 was located in the proximal lad was 10.00 mm long with a reference vessel diameter of 3.00 mm.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS ELEMENT¿ PLUS
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
Manufacturer (Section G)
BOSTON SCIENTIFIC - GALWAY
Manufacturer Contact
sonali arangil
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key6278685
MDR Text Key65767466
Report Number2134265-2017-00372
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P110010
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 01/06/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date08/02/2013
Device Model NumberH7493911424250
Device Catalogue Number39114-2425
Device Lot Number15511281
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/06/2017
Initial Date FDA Received01/26/2017
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received03/15/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/18/2012
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age54 YR
-
-